The First Human Cell Line Recombinant Factor VIII (Human-cl rhFVIII) - Functional Properties and Differences From Currently Available Recombinant Factor VIII Products.

被引：0
|
作者：
Schwartz, Bruce A. [1 ]
Sandberg, Helena [2 ]
Agerkvist, Irene [3 ]
Kannicht, Christoph [4 ]
Ramstrom, Margareta [5 ]
Stenlund, Peter [5 ]
Oswaldsson, Ulla [5 ]
Brunberg, Tobias [5 ]
机构：
[1] Octapharma USA, Hoboken, NJ USA
[2] Octapharma, Stockholm, Sweden
[3] Octapharma, Stockholm, Sweden
[4] Octapharma R&D, Berlin, Germany
[5] Octapharma Biopharmaceut, Stockholm, Sweden
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：532 / 532
页数：1
相关论文
共 50 条
  • [1] Characteristics of the first human cell line recombinant human factor VIII (human-cl rhFVIII)
    Sandberg, H.
    Agerkvist, I
    Kannicht, C.
    Ramstrom, M.
    Stenlund, P.
    Dadaian, M.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 513 - 514
  • [2] Product characteristics of human cell line recombinant factor VIII, (human-cl rhFVIII)
    Sandberg, H.
    Ramstrom, M.
    Stenlund, P.
    Kannicht, C.
    Agerkvist, I.
    [J]. HAEMOPHILIA, 2010, 16 : 39 - 39
  • [3] Product characteristics of human cell line recombinant factor VIII (human-cl rhFVIII)
    Sandberg, H.
    Ramstrom, M.
    Stenlund, P.
    Kannicht, C.
    Agerkvist, I.
    [J]. HAEMOPHILIA, 2011, 17 (02) : 356 - 357
  • [4] Novel, human cell line-derived recombinant factor VIII (human-cl rhFVIII; Nuwiq®) in adults with severe haemophilia A: efficacy and safety
    Lissitchkov, T.
    Hampton, K.
    von Depka, M.
    Hay, C.
    Rangarajan, S.
    Tuddenham, E.
    Holstein, K.
    Huth-Kuehne, A.
    Pabinger, I.
    Knaub, S.
    Bichler, J.
    Oldenburg, J.
    [J]. HAEMOPHILIA, 2016, 22 (02) : 225 - 231
  • [5] Properties of the first human cell line derived human recombinant factor VIII
    Sandberg, H.
    Agerkvist, I.
    Dadaian, M.
    Ramstrom, M.
    Sebring, S.
    Stenlund, P.
    [J]. HAEMOPHILIA, 2009, 15 (02) : 633 - 633
  • [6] Development, upscaling and validation of the purification process for human-cl rhFVIII (Nuwiq®), a new generation recombinant factor VIII produced in a human cell-line
    Winge, Stefan
    Yderland, Louise
    Kannicht, Christoph
    Hermans, Pim
    Adema, Simon
    Schmidt, Torben
    Gilljam, Gustav
    Linhult, Martin
    Tiemeyer, Maya
    Belyanskaya, Larisa
    Walter, Olaf
    [J]. PROTEIN EXPRESSION AND PURIFICATION, 2015, 115 : 165 - 175
  • [7] Novel, human cell line-derived recombinant factor VIII (Human-cl rhFVIII, Nuwiq®) in children with severe haemophilia A: efficacy, safety and pharmacokinetics
    Klukowska, A.
    Szczepanski, T.
    Vdovin, V.
    Knaub, S.
    Jansen, M.
    Liesner, R.
    [J]. HAEMOPHILIA, 2016, 22 (02) : 232 - 239
  • [8] A Prospective, Multi-Center, Randomized Clinical Trial to Compare the Pharmacokinetic Properties of Human-Cl rhFVIII, a New Human-Cell Line Derived Recombinant Factor VIII, with Those of a Full-Length Recombinant Factor VIII Expressed in Baby Hamster Kidney Cells
    Knaub, Sigurd
    Tiede, Andreas
    Lissitchkov, Toshko
    Valentino, Leonard A.
    Powell, Jerry Sherman
    Manco-Johnson, Marilyn J.
    [J]. BLOOD, 2011, 118 (21) : 1423 - 1423
  • [9] A novel recombinant factor VIII expressed in a human cell line
    Sandberg, H.
    Agerkvist, I.
    Lindner, E.
    Martinelle, K.
    Winge, S.
    [J]. HAEMOPHILIA, 2008, 14 : 15 - 15
  • [10] Studies on thermal denaturation and unfolding of recombinant human factor VIII (rhFVIII) in solution
    Kashi, RS
    Edwards, KL
    Hu, L
    Besman, MJ
    Middaugh, RC
    [J]. THROMBOSIS AND HAEMOSTASIS, 1999, : 286 - 286
12345